The authors explored the potential of a formulation of low molecular weight protamine and dextran sulfate for gene delivery.
[Molecular Pharmaceutics]
Home Newsletters Cell Therapy News Protamine-Based Nanotherapeutics for Gene Delivery to Glioblastoma Cells
